Night sweats that disrupt sleep can be a common side effect of fluoxetine and other selective serotonin-reuptake inhibitors (SSRIs), a class of medications used to treat depression and anxiety. These drugs can influence the brain's temperature regulation.
While medication is a potential culprit, other factors can exacerbate sweating, including anxiety, alcohol consumption, and hormonal fluctuations during the menstrual cycle. A physician consultation is recommended, especially if night sweats are a recent development and accompanied by other symptoms like unintentional weight loss or fever. Possible, though less common, causes include an overactive thyroid, viral infections, or tuberculosis.
Previous blood tests likely included checks for thyroid function and markers of inflammation such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), which typically rise with infection or injury. If these results were normal and no other underlying illness is identified, fluoxetine remains the most probable cause. Adjusting the dosage of the medication could potentially alleviate the night sweats.
Low iron levels, while noted, are not generally considered a direct cause of night sweats. A physical examination by a general practitioner is advised to ensure no other medical conditions are present.
If no other cause is identified, reducing the dosage of fluoxetine may help ease the night sweats. Patients experiencing this side effect should discuss it with their GP.
Separately, concerns have been raised regarding proton pump inhibitors (PPIs) such as omeprazole, commonly used for heartburn and acid reflux. New research suggests a potential link between long-term PPI use and an increased risk of conditions like chronic bronchitis and emphysema, potentially leading to more severe infections. Stomach acid plays a crucial role in protein digestion, nutrient absorption, and defending the body against bacteria and viruses. The latest studies indicate that PPIs may facilitate the passage of harmful bacteria from the stomach to the lungs. It is advised to use PPIs at the lowest effective dose and for the shortest duration necessary.